A regulatory view of adaptive trial design.

Journal of the Formosan Medical Association = Taiwan yi zhi

Volumn 107, Issue 12 Suppl, 2008, Pages 3-8

  Wang, Mey ^a   Wu, Ya Chi ^a   Tsai, Guei Feng ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; DRUG SCREENING; HUMAN; METHODOLOGY; PHASE 3 CLINICAL TRIAL; REVIEW; SAMPLE SIZE; STATISTICS;

CLINICAL TRIALS, PHASE III AS TOPIC; DRUG EVALUATION; ENDPOINT DETERMINATION; HUMANS; RESEARCH DESIGN; SAMPLE SIZE; STATISTICS AS TOPIC;

MLCS; MLOWN;

EID: 65449183066     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0929-6646(09)60002-4     Document Type: Review

References (18)